Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

Published:2010-06 Issue:1 Volume:103 Page:36-42
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Iwasa T,Okamoto I,Takezawa K,Yamanaka K,Nakahara T,Kita A,Koutoku H,Sasamata M,Hatashita E,Yamada Y,Kuwata K,Fukuoka M,Nakagawa K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605713.pdf

Reference46 articles.

1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351: 882–883

2. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7: 542–547

3. Altieri DC (2003a) Survivin and apoptosis control. Adv Cancer Res 88: 31–52

4. Altieri DC (2003b) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46–54

5. Altieri DC (2004) Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem 92: 656–663

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer;Respiratory Research;2023-02-17

2. Hypoxia represses early responses of prostate and renal cancer cells to YM155 independent of HIF-1α and HIF-2α;Current Research in Pharmacology and Drug Discovery;2022

3. Survivin as a biological biomarker for diagnosis and therapy;Expert Opinion on Biological Therapy;2021-06-21

4. Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells;International Journal of Molecular Sciences;2020-12-11

5. YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression;Anticancer Research;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3